Affinage

MED16

Mediator of RNA polymerase II transcription subunit 16 · UniProt Q9Y2X0

Round 2 corrected
Length
877 aa
Mass
96.8 kDa
Annotated
2026-04-28
46 papers in source corpus 14 papers cited in narrative 11 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

MED16 is a subunit of the Tail module of the Mediator coactivator complex that bridges gene-specific transcriptional activators to the RNA polymerase II general transcription machinery. Biochemically identified as a stoichiometric component of mammalian Mediator (DRIP/TRAP/SMCC), MED16 mediates ligand-dependent activation by nuclear receptors on chromatin templates and is required for activator-specific transcriptional responses, including heat-shock-factor-driven gene expression and lipopolysaccharide-induced transcription (PMID:10235266, PMID:15297616, PMID:23447536). In yeast, loss of Med16 detaches the entire Tail module from the Head–Middle core, and combined inactivation of Med15 and Med16 is synthetically lethal, demonstrating essential Tail-module functions even when uncoupled from the core complex (PMID:23991176, PMID:24882805). Biallelic loss-of-function variants in human MED16 cause a multiple congenital anomalies–intellectual disability MEDopathy syndrome, with most patient variants disrupting nuclear localization of the protein; knockout is preweaning lethal in mice and impairs neurite outgrowth in patient iPSC-derived neurons (PMID:40081376, PMID:40254158).

Mechanistic history

Synthesis pass · year-by-year structured walk · 9 steps
  1. 1999 High

    Establishing that MED16 is a bona fide subunit of the human Mediator complex answered the foundational question of whether metazoan transcription requires a yeast-like Mediator; purified DRIP/TRAP complexes containing MED16 reconstituted ligand-dependent nuclear-receptor-driven transcription on chromatin.

    Evidence Affinity purification, mass spectrometry, and in vitro chromatin transcription assay using VDR/TR-dependent templates

    PMID:10198638 PMID:10235266

    Open questions at the time
    • No direct demonstration that MED16 itself contacts nuclear receptors versus other Tail subunits
    • Contribution of MED16 versus other subunits within the purified complex not resolved
  2. 2004 Medium

    Demonstrating that MED16 is an activator-specific rather than general coactivator resolved how individual Mediator subunits contribute differentially to gene-selective transcription; MED16 depletion selectively impaired LPS- and DIF-induced genes while leaving housekeeping transcription intact.

    Evidence RNAi depletion of individual Mediator subunits in Drosophila S2 cells with endogenous gene expression and reporter assays

    PMID:15297616

    Open questions at the time
    • Activator-specificity demonstrated only in Drosophila; mammalian generalizability not tested
    • Direct physical interaction between MED16 and the specific activators not biochemically validated
  3. 2004 High

    Proteomic validation across six independent Mediator preparations confirmed MED16 as a consensus mammalian Mediator subunit, settling whether its presence was stoichiometric or substoichiometric.

    Evidence Immunoaffinity purification followed by MudPIT mass spectrometry of six independent Mediator preparations

    PMID:15175163

    Open questions at the time
    • Module assignment within mammalian Mediator not resolved by this approach alone
  4. 2013 High

    Genetic and ChIP experiments in yeast revealed that Med16 anchors the Tail module to the core Mediator and is required for heat-shock-factor-dependent Mediator recruitment to HSP promoters, defining its role as a Tail-module organizer and activator-recruitment platform.

    Evidence ChIP of Mediator subunits and Pol II at HSP promoters, Hsf1 activation-domain truncations, med15Δ/med16Δ single and double deletions, synthetic lethality analysis

    PMID:23447536 PMID:23991176

    Open questions at the time
    • Whether Tail-module detachment upon Med16 loss also occurs in mammalian cells was untested
    • Structural basis for Med16-dependent Tail–core interaction not resolved
  5. 2014 High

    Cryo-EM and subunit-localization studies placed Med16 within the Tail module structurally, confirming its conserved position between yeast and human Mediator and revealing large-scale conformational changes at module interfaces.

    Evidence Single-particle electron microscopy with antibody labeling, partial X-ray structure docking

    PMID:24882805

    Open questions at the time
    • Resolution insufficient for atomic-level contacts of MED16 with neighboring subunits
    • Conformational dynamics of MED16-containing module during transcription initiation not captured
  6. 2022 Medium

    Linking MED16 to mTOR-dependent autophagy and tamoxifen resistance in breast cancer cells expanded its functional scope beyond classical transcription coactivation to signaling-coupled cell-fate decisions.

    Evidence siRNA knockdown in ER+ breast cancer cell lines with proliferation, cell cycle, autophagy, and stemness assays; mTOR inhibitor rescue of tamoxifen sensitivity

    PMID:36294896

    Open questions at the time
    • Mechanism connecting MED16 transcriptional activity to mTOR pathway regulation not identified
    • Findings from a single lab with siRNA; genetic knockout confirmation lacking
    • Relevance to in vivo tumor biology not established
  7. 2025 High

    Discovery that biallelic MED16 loss-of-function variants cause a human MEDopathy syndrome — with most variants mislocalizing the protein from nucleus to cytoplasm — established nuclear localization as essential and defined MED16 as a disease gene for intellectual disability with congenital anomalies.

    Evidence Exome/genome sequencing of 25 individuals across 18 families, immunofluorescence of 17 patient variants, homozygous zebrafish mutant, Med16 knockout mouse lethality

    PMID:40081376

    Open questions at the time
    • How specific variants alter Mediator complex integrity or activator recruitment is unknown
    • Tissue-specific transcriptional consequences of hypomorphic alleles not characterized
  8. 2025 High

    Functional validation in Drosophila and patient iPSC-derived neurons demonstrated that MED16 loss impairs synaptic transmission and neurite outgrowth, with rescue by exogenous MED16 expression confirming loss-of-function pathogenicity and revealing preferential dysregulation of neuronal-maturation genes.

    Evidence Drosophila med16 knockout with electrophysiology and behavior, patient iPSC-derived neuron differentiation with neurite outgrowth assay and rescue, transcriptomic profiling

    PMID:40254158

    Open questions at the time
    • Which downstream transcriptional targets are direct versus indirect is unresolved
    • Whether MED16 variants disrupt specific activator interactions in neurons is not determined
  9. 2025 Medium

    Identification of a free MED16–UBP1–TFCP2 subcomplex that can activate or repress transcription depending on TSS-proximal motif architecture revealed that MED16 has functions independent of the holo-Mediator complex, including suppression of HIV-1 transcription.

    Evidence Protein purification with mass spectrometry, gene expression analysis, HIV-1 reporter assays, ChIP/ATAC-seq motif positioning (preprint)

    PMID:bio_10.1101_2025.08.12.669905

    Open questions at the time
    • Preprint not yet peer-reviewed
    • Stoichiometry and stability of the free subcomplex in vivo not established
    • Whether MED16 dissociation from Mediator is regulated or constitutive is unknown

Open questions

Synthesis pass · forward-looking unresolved questions
  • Key unresolved questions include the atomic-resolution structure of MED16 within human Mediator, the identity of MED16's direct activator-binding surfaces, the mechanism by which MED16 loss leads to mTOR pathway dysregulation, and whether the free MED16–UBP1–TFCP2 subcomplex operates in developing neurons to explain the neurodevelopmental phenotype.
  • No high-resolution structure of MED16 within the human Mediator Tail module
  • Direct activator-binding interfaces on MED16 not mapped
  • Relationship between Mediator-independent MED16 functions and disease phenotype untested

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0140110 transcription regulator activity 4
Localization
GO:0005634 nucleus 2
Pathway
R-HSA-74160 Gene expression (Transcription) 4 R-HSA-1266738 Developmental Biology 2 R-HSA-9612973 Autophagy 1
Partners
HSF1MED15TFCP2UBP1
Complex memberships
MED16-UBP1-TFCP2 subcomplexMediator complex (Tail module)

Evidence

Reading pass · 11 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2004 Drosophila MED16 (and MED23) were identified as subunit-specific coactivators within the Mediator complex: RNAi depletion of MED16 specifically impaired lipopolysaccharide-induced and differentiation-inducing factor (DIF)-induced transcription, and MED16's activator-specific function appeared to result from direct interaction with specific upstream activators, while depletion of other subunits caused general transcriptional defects. RNA interference depletion of individual Mediator subunits in Drosophila S2 cells, endogenous gene expression assays, synthetic promoter reporter assays, microarray analysis Proceedings of the National Academy of Sciences of the United States of America Medium 15297616
1999 MED16 (as TRAP/DRIP subunit) was identified as a component of the DRIP/TRAP/SMCC/Mediator coactivator complex that directly mediates ligand-dependent transcriptional activation by nuclear receptors (VDR, TR) on chromatin templates in cell-free transcription assays; the complex was purified and subunit identities determined by mass spectrometry. Affinity purification, mass spectrometry, in vitro chromatin transcription assay Nature; Molecular cell High 10198638 10235266
2004 MED16 was identified as a consensus subunit of the mammalian Mediator complex by multidimensional protein identification technology (MudPIT) across six independent immunoaffinity-purified Mediator preparations, establishing it as a core component of the mammalian Mediator. Immunoaffinity purification followed by MudPIT mass spectrometry, six independent Mediator preparations Molecular cell High 15175163
2013 In yeast Saccharomyces cerevisiae, Med16 (a Tail module subunit) is required for holo-Mediator recruitment to HSP gene promoters in response to heat shock; ablation of Med16 (or Med15) individually reduced Mediator occupancy at HSP promoters, while deletion of both abolished it, concomitantly diminishing RNA polymerase II recruitment. Hsf1 recruits Mediator via its dual N- and C-terminal activation domains cooperating with the Tail module. ChIP of Mediator subunits and RNA Pol II at HSP promoters, truncation analysis of Hsf1 activation domains, genetic deletion of Med15 and Med16 The Journal of biological chemistry High 23447536
2013 In yeast, cells lacking Med16 displace the entire Tail module from the Head and Middle modules of Mediator. Inactivation of MED15/MED16 together is synthetically lethal, indicating that the Tail performs essential functions even when separated from the core complex. Loss of Med15 (but not Med16 alone) causes G1 cell cycle arrest coinciding with downregulation of Ace2 transcription factor target genes. N-Degron temperature-sensitive mutants, global gene expression analysis, genetic interaction/synthetic lethality, cell cycle analysis PloS one Medium 23991176
2014 Cryo-EM structural analysis and subunit localization experiments placed Med16 within the Tail module of the Mediator complex; large-scale conformational rearrangements of Mediator depend on changes at module interfaces, and the Tail module position (where Med16 resides) is conserved between yeast and human Mediator. Single-particle electron microscopy, subunit localization by antibody labeling, partial X-ray structure docking, biochemical module analysis Cell High 24882805
2015 High-throughput affinity-purification mass spectrometry (BioPlex) identified MED16 as an interaction partner within the human Mediator complex network in HEK293T cells, placing it in a community of Mediator subunits consistent with the Tail module. Affinity purification mass spectrometry (AP-MS) at proteome scale in HEK293T cells Cell Medium 26186194 28514442 33961781
2022 In human ER-positive breast cancer cells, MED16 knockdown inhibited cell proliferation, promoted G1 phase cell cycle arrest, reduced tamoxifen sensitivity, and increased autophagy and cancer stem cell properties. The mTOR signaling pathway was regulated by MED16 expression levels, and pharmacological inhibition of mTOR-mediated autophagy restored tamoxifen sensitivity lost upon MED16 downregulation. siRNA knockdown of MED16 in ER+ BC cell lines, cell proliferation assay, flow cytometry (cell cycle), tamoxifen sensitivity assay, autophagy and stemness assays, mTOR pathway inhibitor rescue Life (Basel, Switzerland) Medium 36294896
2025 Bi-allelic loss-of-function variants in human MED16 cause a multiple congenital anomalies-intellectual disability MEDopathy syndrome. Immunofluorescence assays demonstrated that 16 of 17 patient variants caused mislocalization of MED16 protein from nucleus to cytoplasm, establishing nuclear localization as functionally critical. Homozygous med16 mutant zebrafish showed growth delay and increased mortality; Med16 knockout mice were preweaning lethal. Exome/genome sequencing of 25 individuals from 18 families, immunofluorescence of patient-variant proteins, homozygous zebrafish mutant phenotyping, Med16 knockout mouse lethality American journal of human genetics High 40081376
2025 Biallelic MED16 variants in humans cause neurodevelopmental disease; the Drosophila ortholog med16 is expressed in CNS neurons and glia, and loss of med16 impairs synaptic transmission and reduces eclosion/lifespan. In iPSC-derived neurons from patients, neurite outgrowth was impaired and rescued by exogenous MED16 expression, establishing loss-of-function pathogenicity. Patient variants preferentially altered transcription of genes related to neuronal maturation. Drosophila med16 knockout (electrophysiology, behavioral assays), patient iPSC-derived neuron differentiation, neurite outgrowth assay with rescue by exogenous MED16, transcriptomic analysis Journal of genetics and genomics High 40254158
2025 Human MED16 dissociates from the core Mediator complex to form a subcomplex with transcription factors UBP1 and TFCP2, identified by protein purification and mass spectrometry. The MED16-UBP1 interaction activates silenced genes involved in lung homeostasis, angiogenesis, and cell proliferation, but suppresses HIV-1 transcription by cooperatively binding near the viral transcriptional start site to inhibit preinitiation complex assembly. Transcriptional outcome (activation vs. repression) depends on whether the UBP1-TFCP2 binding motif is proximal to or overlaps the TSS. Protein purification coupled with mass spectrometry, gene expression analysis, HIV-1 reporter assays, genomic-scale (ChIP/ATAC) analysis of TSS motif positioning bioRxivpreprint Medium bio_10.1101_2025.08.12.669905

Source papers

Stage 0 corpus · 46 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2002 Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proceedings of the National Academy of Sciences of the United States of America 1479 12477932
2015 The BioPlex Network: A Systematic Exploration of the Human Interactome. Cell 1118 26186194
2017 Architecture of the human interactome defines protein communities and disease networks. Nature 1085 28514442
2015 A human interactome in three quantitative dimensions organized by stoichiometries and abundances. Cell 1015 26496610
2021 Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. Cell 705 33961781
2012 A census of human soluble protein complexes. Cell 689 22939629
2011 Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Briefings in bioinformatics 656 21873635
1999 Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 583 10235266
2010 An atlas of combinatorial transcriptional regulation in mouse and man. Cell 573 20211142
2009 Centromere-specific assembly of CENP-a nucleosomes is mediated by HJURP. Cell 555 19410544
1996 Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. Proceedings of the National Academy of Sciences of the United States of America 466 8710870
2005 Integrator, a multiprotein mediator of small nuclear RNA processing, associates with the C-terminal repeat of RNA polymerase II. Cell 443 16239144
2004 The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome research 438 15489334
2022 OpenCell: Endogenous tagging for the cartography of human cellular organization. Science (New York, N.Y.) 432 35271311
2015 Panorama of ancient metazoan macromolecular complexes. Nature 407 26344197
1999 Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators. Molecular cell 353 10198638
2010 CDK8 is a positive regulator of transcriptional elongation within the serum response network. Nature structural & molecular biology 298 20098423
2011 Human mediator subunit MED26 functions as a docking site for transcription elongation factors. Cell 281 21729782
2004 A set of consensus mammalian mediator subunits identified by multidimensional protein identification technology. Molecular cell 265 15175163
2014 Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes. Journal of proteomics 215 25281560
2003 Coordination of p300-mediated chromatin remodeling and TRAP/mediator function through coactivator PGC-1alpha. Molecular cell 210 14636573
2018 An AP-MS- and BioID-compatible MAC-tag enables comprehensive mapping of protein interactions and subcellular localizations. Nature communications 201 29568061
2001 Identification and characterization of the potential promoter regions of 1031 kinds of human genes. Genome research 188 11337467
2013 The protein interaction landscape of the human CMGC kinase group. Cell reports 174 23602568
2020 UFMylation maintains tumour suppressor p53 stability by antagonizing its ubiquitination. Nature cell biology 168 32807901
2014 Subunit architecture and functional modular rearrangements of the transcriptional mediator complex. Cell 163 24882805
2020 Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer. Molecular cell 159 32416067
2018 Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. Molecular cell 136 30554943
2002 The TRAP/Mediator coactivator complex interacts directly with estrogen receptors alpha and beta through the TRAP220 subunit and directly enhances estrogen receptor function in vitro. Proceedings of the National Academy of Sciences of the United States of America 134 11867769
2015 FBXW7 modulates cellular stress response and metastatic potential through ​HSF1 post-translational modification. Nature cell biology 130 25720964
2014 The Arabidopsis Mediator subunit MED16 regulates iron homeostasis by associating with EIN3/EIL1 through subunit MED25. The Plant journal : for cell and molecular biology 112 24456400
2014 The Arabidopsis mediator complex subunits MED16, MED14, and MED2 regulate mediator and RNA polymerase II recruitment to CBF-responsive cold-regulated genes. The Plant cell 95 24415770
2013 Mediator recruitment to heat shock genes requires dual Hsf1 activation domains and mediator tail subunits Med15 and Med16. The Journal of biological chemistry 65 23447536
2004 MED16 and MED23 of Mediator are coactivators of lipopolysaccharide- and heat-shock-induced transcriptional activators. Proceedings of the National Academy of Sciences of the United States of America 59 15297616
2017 Mediator Complex Subunits MED2, MED5, MED16, and MED23 Genetically Interact in the Regulation of Phenylpropanoid Biosynthesis. The Plant cell 49 29203634
2016 The Mediator Complex Subunits MED14, MED15, and MED16 Are Involved in Defense Signaling Crosstalk in Arabidopsis. Frontiers in plant science 38 28066497
2019 Transcriptional Repression of the APC/C Activator Genes CCS52A1/A2 by the Mediator Complex Subunit MED16 Controls Endoreduplication and Cell Growth in Arabidopsis. The Plant cell 34 31175173
2021 Mediator tail module subunits MED16 and MED25 differentially regulate abscisic acid signaling in Arabidopsis. Journal of integrative plant biology 32 33369119
2021 Mediator Subunits MED16, MED14, and MED2 Are Required for Activation of ABRE-Dependent Transcription in Arabidopsis. Frontiers in plant science 15 33777083
2013 Functional studies of the yeast med5, med15 and med16 mediator tail subunits. PloS one 13 23991176
2025 A multiprotein regulatory module, MED16-MBR1&2, controls MED25 homeostasis during jasmonate signaling. Nature communications 9 39824838
2022 MED16 Promotes Tumour Progression and Tamoxifen Sensitivity by Modulating Autophagy through the mTOR Signalling Pathway in ER-Positive Breast Cancer. Life (Basel, Switzerland) 5 36294896
2025 Bi-allelic MED16 variants cause a MEDopathy with intellectual disability, motor delay, and craniofacial, cardiac, and limb malformations. American journal of human genetics 4 40081376
2021 Pantoea Bacteriophage vB_PagS_MED16-A Siphovirus Containing a 2'-Deoxy-7-amido-7-deazaguanosine-Modified DNA. International journal of molecular sciences 3 34298953
2025 Biallelic MED16 variants disrupt neural development and lead to an intellectual disability syndrome. Journal of genetics and genomics = Yi chuan xue bao 1 40254158
2026 When MED16 Meets Plant Growth, Development, and Stress Response. International journal of molecular sciences 0 41828689